Financial statements Notes to the financial statements 31 Contingent liabilities At 31 December 2013, contingent liabilities, comprising guarantees, discounted bills and other items arising in the normal course of business, amounted to 198 million 2012 209 million.
At 31 December 2013, nil 2012 nil of financial assets were pledged as collateral for contingent liabilities.
Provision is made for the outcome of tax, legal and other disputes where it is both probable that the Group will suffer an outflow of funds and it is possible to make a reliable estimate of that outflow.
At 31 December 2013, other than for those disputes where provision has been made, it was not possible to make a reliable estimate of the potential outflow of funds that might be required to settle disputes where the possibility of there being an outflow was more than remote.
Descriptions of the significant tax, legal and other disputes to which the Group is a party are set out in Note 14, Taxation and Note 44, Legal proceedings.
32 Net debt 2013 2012 Listing exchange m m Current assets: Liquid investments 66 81 Cash and cash equivalents 5,534 4,184 5,600 4,265 Short-term borrowings: Bank loans and overdrafts 352 323 Commercial paper 1,491 1,748 Obligations under finance leases 27 27 4.85% US$ US Medium Term Note 2013 New York Stock Exchange 1,533 London Stock Exchange 919 4.375% US$ US Medium Term Note 2014 2,789 3,631 Long-term borrowings: 4.375% US$ US Medium Term Note 2014 London Stock Exchange 970 0.75% US$ US Medium Term Note 2015 New York Stock Exchange 601 611 3.875% European Medium Term Note 2015 London Stock Exchange 1,330 1,296 0.7% US$ US Medium Term Note 2016 New York Stock Exchange 751 1.50% US$ US Medium Term Note 2017 New York Stock Exchange 1,199 1,219 5.625% European Medium Term Note 2017 London Stock Exchange 1,038 1,013 5.65% US$ US Medium Term Note 2018 New York Stock Exchange 1,653 1,683 2.85% US$ US Medium Term Note 2022 New York Stock Exchange 1,193 1,214 2.8% US$ US Medium Term Note 2023 New York Stock Exchange 743 4.00% European Medium Term Note 2025 London Stock Exchange 618 602 3.375% European Medium Term Note 2027 London Stock Exchange 591 590 5.25% European Medium Term Note 2033 London Stock Exchange 983 982 5.375% US$ US Medium Term Note 2034 London Stock Exchange 299 305 6.375% US$ US Medium Term Note 2038 New York Stock Exchange 1,641 1,670 6.375% European Medium Term Note 2039 London Stock Exchange 694 694 5.25% European Medium Term Note 2042 London Stock Exchange 987 986 4.2% US$ US Medium Term Note 2043 New York Stock Exchange 294 4.25% European Medium Term Note 2045 London Stock Exchange 788 787 Obligations under finance leases 53 49 15,456 14,671 Net debt 12,645 14,037 174 GSK Annual Report 2013
